Univest
Univest
  • Markets

Anthem Biosciences Share Price Rising Today: Stock Jumps 2.13% to Rs 775.10 on 17 July 2026

  • July 17, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Anthem Biosciences Share Price Rising Today
 

Anthem Biosciences share price rising today, up 2.13% to Rs 775.10. Day range Rs 754.60 to Rs 782.95. Volume 20.33 lakh.

The Anthem Biosciences share price is rising today, up 2.13% to Rs 775.10 on the NSE in trade on 17 July 2026, as Anthem Biosciences features among the top gainers in the broader market. The stock opened at Rs 759.05 against the previous close of Rs 758.95 and has moved between a low of Rs 754.60 and a high of Rs 782.95 during the session.

Trading volumes have been elevated, with around 20.33 lakh shares changing hands, reflecting strong participation behind today’s move. Anthem Biosciences’ move today comes amid sustained investor interest in India’s contract research, development, and manufacturing organisation, or CRDMO, sector.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Anthem Biosciences Share Price Rising Today: Trading Snapshot
  • Why the Anthem Biosciences Share Price Is Rising Today
  • About Anthem Biosciences
  • Anthem Biosciences Share Price Rising Today: What Should Investors Watch
  • Conclusion
  • Frequently Asked Questions FAQs
    • Why is the Anthem Biosciences share price rising today?
    • What is the Anthem Biosciences share price today?
    • How much trading volume has Anthem Biosciences seen today?
    • What does Anthem Biosciences do?
    • Is the Anthem Biosciences share price rising today a buying signal?
    • What should investors watch for the Anthem Biosciences share price?
    • Where can I track the Anthem Biosciences share price live?

Anthem Biosciences Share Price Rising Today: Trading Snapshot

The table below summarises the Anthem Biosciences share price action as of the latest trade on 17 July 2026.

Parameter Value
CMP Rs 775.10
Change +2.13%
Day Open Rs 759.05
Day High Rs 782.95
Day Low Rs 754.60
Previous Close Rs 758.95
Volume 20.33 lakh shares

Prices and volumes are from trade on 17 July 2026 and will keep changing through the session. The Anthem Biosciences share price rising today against this kind of elevated volume base typically signals more than routine day to day trading interest.

Consult a SEBI-Registered Investment Advisor at Univest

Why the Anthem Biosciences Share Price Is Rising Today

Anthem Biosciences, which operates as a contract research, development, and manufacturing organisation, or CRDMO, for pharmaceutical and biotechnology clients, is rising today amid continued investor interest in India’s growing CRDMO sector. Global pharmaceutical companies have increasingly outsourced research and manufacturing to Indian CRDMO players, a structural growth theme that has supported the sector’s valuations.

The company’s diversified service offering, spanning drug discovery, development, and commercial manufacturing for global biotech and pharma clients, positions it to benefit from the broader trend of pharmaceutical companies seeking cost efficient, high quality outsourced research and manufacturing partners.

About Anthem Biosciences

Anthem Biosciences is a contract research, development, and manufacturing organisation providing drug discovery, development, and commercial manufacturing services to global pharmaceutical and biotechnology companies from its facilities in India.

Anthem Biosciences Share Price Rising Today: What Should Investors Watch

Investors should track new client wins and contract announcements, capacity utilisation and expansion at manufacturing facilities, and broader trends in global pharmaceutical outsourcing to Indian CRDMO players.

Investors should avoid chasing the Anthem Biosciences share price purely because it is rising today, and instead evaluate whether the underlying business rationale supports the move before making any investment decision.

Download the Univest iOS App or Univest Android App to track the Anthem Biosciences share price live and get daily stock research.

Conclusion

The Anthem Biosciences share price is rising today, up 2.13% to Rs 775.10 on 17 July 2026, with volumes well above typical levels. Continued investor interest in India’s growing CRDMO sector appears to be supporting today’s gain in this contract research and manufacturing company. Investors should track further developments and consult a SEBI-registered advisor before making investment decisions based on the Anthem Biosciences share price rising today.

Volumes in the first half of the trading session are often the heaviest on days with sharp stock specific moves, before activity moderates into the close.

Investors should also check whether peer stocks in the same sector are moving in tandem, which can indicate a broader theme rather than a stock specific development.

Quarterly results, management commentary, and sector data released in the coming weeks will offer more clarity on whether today’s strength is likely to hold.

Volumes in the first half of the trading session are often the heaviest on days with sharp stock specific moves, before activity moderates into the close.

Momentum traders watching the Anthem Biosciences share price rising today often use volume confirmation, like today’s elevated turnover, as a signal that the move has genuine participation behind it rather than being a thin, low-volume spike.

Analysts typically wait for a day or two of follow-through before treating a single session’s rise in the Anthem Biosciences share price as the start of a sustained trend rather than a one-off event.

Investors should also check whether peer stocks in the same sector are moving in tandem, which can indicate a broader theme rather than a stock specific development.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions FAQs

Why is the Anthem Biosciences share price rising today?

Ans. The Anthem Biosciences share price is rising today, up 2.13% to Rs 775.10 on 17 July 2026. Anthem Biosciences is rising today amid continued investor interest in India’s CRDMO sector, as global pharmaceutical companies increasingly outsource research and manufacturing to Indian players.

What is the Anthem Biosciences share price today?

Ans. The Anthem Biosciences share price is trading at Rs 775.10 on the NSE on 17 July 2026, up 2.13% from the previous close of Rs 758.95, with the stock moving between Rs 754.60 and Rs 782.95 during the session.

How much trading volume has Anthem Biosciences seen today?

Ans. Anthem Biosciences has traded with volumes of around 20.33 lakh shares so far today, reflecting elevated participation compared to typical sessions.

What does Anthem Biosciences do?

Ans. Anthem Biosciences is a contract research, development, and manufacturing organisation providing drug discovery, development, and commercial manufacturing services to global pharma and biotech clients.

Is the Anthem Biosciences share price rising today a buying signal?

Ans. A single day’s rise is not a reliable buying signal on its own. Evaluate the underlying business rationale, valuations, and your own risk appetite before making any investment decision, and consult a SEBI-registered advisor.

What should investors watch for the Anthem Biosciences share price?

Ans. Watch new client wins and contract announcements, capacity utilisation and expansion, and broader trends in global pharmaceutical outsourcing to Indian CRDMO players.

Where can I track the Anthem Biosciences share price live?

Ans. You can track the Anthem Biosciences share price live on NSE and BSE, or on the Univest app, which also provides daily research and market updates on Indian stocks.



News
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply